Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.

Kusturica, Jasna; Kulo Cesic, Aida; Gusic, Edis; Maleskic, Sanita; Rakanovic-Todic, Maida; Secic, Damir

Kusturica, Jasna; Kulo Cesic, Aida; Gusic, Edis; Maleskic, Sanita; Rakanovic-Todic, Maida; Secic, Damir.

Affiliation

Kusturica J; Department of Pharmacology and Toxicology, School of Medicine, University of Sarajevo, Bosnia and Herzegovina.
Kulo Cesic A; Department of Pharmacology and Toxicology, School of Medicine, University of Sarajevo, Bosnia and Herzegovina.
Gusic E; Department of Health Care, Ministry of Internal Affairs of Canton Sarajevo, Bosnia and Herzegovina.
Maleskic S; Department of Pharmacology and Toxicology, School of Medicine, University of Sarajevo, Bosnia and Herzegovina.
Rakanovic-Todic M; Department of Pharmacology and Toxicology, School of Medicine, University of Sarajevo, Bosnia and Herzegovina.
Secic D; Department of Pathophysiology, School of Medicine, University of Sarajevo; Sarajevo, Bosnia and Herzegovina.

Med Glas (Zenica) ; 14(2): 176-181, 2017 Aug 01.

Article in En | MEDLINE | ID: mdl-28698536

Subject(s)

Carcinoma/epidemiology; Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Metformin/therapeutic use; Neoplasms/epidemiology; Adult; Aged; Cross-Sectional Studies; Female; Humans; Hypoglycemic Agents/adverse effects; Logistic Models; Male; Metformin/adverse effects; Middle Aged; Prevalence

Key words

hypoglycemic agents; neoplasms; type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Metformin / Neoplasms Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Med Glas (Zenica) Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google